MRI contraindications - Revision history

Rossdonaldson1: /* See Also */

2023-03-01T22:02:50Z

Ostermayer: /* References */

2023-02-23T16:08:19Z

References

← Older revision		Revision as of 16:08, 23 February 2023
Line 99:		Line 99:

	==References==		==References==
			<references/>

	[[Category:Radiology]]		[[Category:Radiology]]

Ostermayer: /* References */

2023-02-23T16:07:35Z

References

← Older revision		Revision as of 16:07, 23 February 2023
Line 99:		Line 99:

	==References==		==References==
	~~<references>~~

	[[Category:Radiology]]		[[Category:Radiology]]

Ostermayer: /* MR (Gadolinium-Based) Contrast25.Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society f...

2023-02-23T16:07:08Z

/* MR (Gadolinium-Based) Contrast25.Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society f...

← Older revision		Revision as of 16:07, 23 February 2023
Line 77:		Line 77:
	*Very Obese (depending on system)		*Very Obese (depending on system)

	==MR (Gadolinium-Based) Contrast<ref>25.Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007; 116:2878.</ref>==		==MR (Gadolinium-Based) Contrast==
	===Background===		===Background===
	*Unlike iodinated contrast, MR contrast has few side effects and rarely cause [[anaphylaxis]]		*Unlike iodinated contrast, MR contrast has few side effects and rarely cause [[anaphylaxis]]

Ostermayer: /* MR Contraindications25.Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiov...

2023-02-23T16:06:24Z

/* MR Contraindications25.Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiov...

← Older revision		Revision as of 16:06, 23 February 2023
Line 1:		Line 1:
	==MR Contraindications<ref>25.Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007; 116:2878.</ref>==		==MR Contraindications==

	===Cardiovascular Devices===		===Cardiovascular Devices===
Line 38:		Line 38:

	====Permanent pacemakers and implantable ICDs====		====Permanent pacemakers and implantable ICDs====
	*Only if no alternative diagnostic test is available and the potential benefit to the patient clearly outweighs the potential risks		*Only if no alternative diagnostic test is available and the potential benefit to the patient clearly outweighs the potential risks<ref>Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007; 116:2878.</ref>
	*If performed, the pacemaker/ICD should be interrogated before and after the procedure		*If performed, the pacemaker/ICD should be interrogated before and after the procedure
	*Registry of non-MRI conditional pacemakers in NEJM article with nonthoracic MRI at field strength of 1.5 teslas suggested that lead or device failure does not occur<ref>Russo RJ et al. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator. N Engl J Med 2017; 376:755-764. February 23, 2017.</ref>		*Registry of non-MRI conditional pacemakers in NEJM article with nonthoracic MRI at field strength of 1.5 teslas suggested that lead or device failure does not occur<ref>Russo RJ et al. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator. N Engl J Med 2017; 376:755-764. February 23, 2017.</ref>

Kxl328 at 03:42, 28 February 2017

2017-02-28T03:42:15Z

← Older revision		Revision as of 03:42, 28 February 2017
Line 41:		Line 41:
	*If performed, the pacemaker/ICD should be interrogated before and after the procedure		*If performed, the pacemaker/ICD should be interrogated before and after the procedure
	*Registry of non-MRI conditional pacemakers in NEJM article with nonthoracic MRI at field strength of 1.5 teslas suggested that lead or device failure does not occur<ref>Russo RJ et al. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator. N Engl J Med 2017; 376:755-764. February 23, 2017.</ref>		*Registry of non-MRI conditional pacemakers in NEJM article with nonthoracic MRI at field strength of 1.5 teslas suggested that lead or device failure does not occur<ref>Russo RJ et al. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator. N Engl J Med 2017; 376:755-764. February 23, 2017.</ref>
	**In 1000 cases of pacemakers and 500 cases of ICD		**1000 cases of pacemakers and 500 cases of ICD in study
	**No deaths, lead failures, losses of capture, or ventricular arrhythmias occurred during MRI		**No deaths, lead failures, losses of capture, or ventricular arrhythmias occurred during MRI
	**Industry funded study, with strict criteria for inclusion		**Industry funded study, with strict criteria for inclusion

Kxl328 at 03:41, 28 February 2017

2017-02-28T03:41:45Z

← Older revision		Revision as of 03:41, 28 February 2017
Line 40:		Line 40:
	*Only if no alternative diagnostic test is available and the potential benefit to the patient clearly outweighs the potential risks		*Only if no alternative diagnostic test is available and the potential benefit to the patient clearly outweighs the potential risks
	*If performed, the pacemaker/ICD should be interrogated before and after the procedure		*If performed, the pacemaker/ICD should be interrogated before and after the procedure
			*Registry of non-MRI conditional pacemakers in NEJM article with nonthoracic MRI at field strength of 1.5 teslas suggested that lead or device failure does not occur<ref>Russo RJ et al. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator. N Engl J Med 2017; 376:755-764. February 23, 2017.</ref>
			**In 1000 cases of pacemakers and 500 cases of ICD
			**No deaths, lead failures, losses of capture, or ventricular arrhythmias occurred during MRI
			**Industry funded study, with strict criteria for inclusion
	*Risks:		*Risks:
	**~~pacemaker~~/ICD dysfunction		**Pacemaker/ICD dysfunction
	**~~pacemaker~~/ICD damage		**Pacemaker/ICD damage
	**~~arrhythmia~~		**Arrhythmia
	**~~death~~		**Death

	===Non-Cardiovascular===		===Non-Cardiovascular===

Neil.m.young at 12:27, 17 June 2016

2016-06-17T12:27:09Z

← Older revision		Revision as of 12:27, 17 June 2016
Line 94:		Line 94:
	*[[MRI (main)]]		*[[MRI (main)]]

	==~~Source~~==		==References==
	<references>		<references>

	[[Category:Radiology]]		[[Category:Radiology]]

Ostermayer: Text replacement - "Category:Rads" to "Category:Radiology"

2016-03-22T16:15:14Z

Text replacement - "Category:Rads" to "Category:Radiology"

← Older revision		Revision as of 16:15, 22 March 2016
Line 97:		Line 97:
	<references>		<references>

	[[Category:~~Rads~~]]		[[Category:Radiology]]

Kxl328: /* MR (Gadolinium-Based) Contrast25.Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventiona...

2016-02-16T05:08:01Z

← Older revision		Revision as of 05:08, 16 February 2016
Line 84:		Line 84:
	**Contrast nephropathy can occur (contraindicated)		**Contrast nephropathy can occur (contraindicated)
	*Dialysis and hepatorenal patients in the perioperative liver transplant period		*Dialysis and hepatorenal patients in the perioperative liver transplant period
	**Associated ~~nephrogenic systemic fibrosis~~ (contraindicated)		**Associated [[Nephrogenic Systemic Fibrosis]] (contraindicated)

	==Key==		==Key==

← Older revision		Revision as of 22:02, 1 March 2023
Line 97:		Line 97:
	==See Also==		==See Also==
	*[[MRI (main)]]		*[[MRI (main)]]
			*[[CT/MRI size limits]]

	==References==		==References==